boric acid has been researched along with Candidiasis, Genital in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.41) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 11 (40.74) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Ghanem, KG; Handa, VL; Kretz, A; Levine, M; Mittelstaedt, R; Powell, A; Sobel, JD; Tuddenham, S | 1 |
| Gerstein, AC; Salama, OE | 1 |
| Chen, Y; Gao, H; Guo, X; Jing, T; Li, X; Li, Y; Liu, Z; Xu, Y | 1 |
| Becker, M; File, B; Nyirjesy, P; Sobel, R | 1 |
| Brotman, RM; Ghanem, KG; Powell, A; Rogers, L; Tuddenham, S; Zenilman, J; Zinalabedini, A | 1 |
| Sobel, JD; Sobel, R | 1 |
| Gracely, E; Nyirjesy, P; Powell, AM | 1 |
| Aklamli, M; Amiri, MM; Arianpour, N; Khameneie, KM; Roozegar, R | 1 |
| De Seta, F; Essmann, M; Larsen, B; Schmidt, M; Vu, B | 1 |
| Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S | 1 |
| Mendez, FJ; Otero, L; Palacio, V; Vazquez, F | 1 |
| Chaim, W; Leaman, D; Nagappan, V; Sobel, JD | 1 |
| Battaglia, F; Fadda, G; Masucci, L; Plotti, G; Posteraro, B; Romano, L; Sanguinetti, M; Zanetti, S | 1 |
| Wilson, C | 1 |
| Anglana, F; Battaglia, F; Mariani, L; Milite, V; Plotti, F; Plotti, G; Quattrini, M; Tomao, F | 1 |
| Banerjee, U; Dadhwal, V; Goswami, D; Goswami, R; Kochupillai, N; Mandal, P; Ray, D; Sreenivas, V | 1 |
| Banerjee, U; Dadhwal, V; Goswami, D; Goswami, R; Kochupillai, N; Ray, D | 1 |
| Orley, J | 1 |
| Hart, LL; Thai, L | 1 |
| Shinohara, YT; Tasker, SA | 1 |
| Culver, BD | 1 |
| Fleites, A; Méndez, FJ; Otero, L; Palacio, V; Vázquez, F | 1 |
| Ringdahl, EN | 1 |
| Morgan, M; Nichols, WS; Silverman, NS | 1 |
| Congema, E; Jovanovic, R; Nguyen, HT | 1 |
| Bingham, JS | 1 |
6 review(s) available for boric acid and Candidiasis, Genital
| Article | Year |
|---|---|
Data on Safety of Intravaginal Boric Acid Use in Pregnant and Nonpregnant Women: A Narrative Review.
Topics: Administration, Intravaginal; Adult; Boric Acids; Candidiasis, Vulvovaginal; Female; Humans; Pregnancy; Vaginosis, Bacterial | 2021 |
Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests | 2018 |
Recurrent vulvovaginitis candidiasis; an overview of traditional and alternative therapies.
Topics: Anti-Infective Agents, Local; Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Causality; Complementary Therapies; Drug Prescriptions; Drug Resistance, Fungal; Female; Garlic; Humans; Lactobacillus acidophilus; Nonprescription Drugs; Prevalence; Recurrence; Self Care; Tea Tree Oil; Treatment Outcome; Yogurt | 2005 |
[Vulvovaginal candidiasis: a therapeutic approach].
Topics: Antifungal Agents; Boric Acids; Candida albicans; Candidiasis, Vulvovaginal; Female; Humans | 2005 |
Boric acid vaginal suppositories.
Topics: Adult; Boric Acids; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Humans; Pessaries | 1993 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
4 trial(s) available for boric acid and Candidiasis, Genital
| Article | Year |
|---|---|
FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Fluconazole; Humans; Iran; Secondary Prevention; Treatment Outcome | 2013 |
Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Boric Acids; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Middle Aged; Suppositories; Vagina | 2007 |
Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Diabetes Mellitus, Type 2; Female; Fluconazole; Humans; Middle Aged; Prospective Studies; Suppositories; Time Factors; Treatment Outcome | 2007 |
Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; Predictive Value of Tests; Recurrence; Vaginal Smears | 1991 |
17 other study(ies) available for boric acid and Candidiasis, Genital
| Article | Year |
|---|---|
Differential Response of
Topics: Antifungal Agents; Boric Acids; Candida; Candida albicans; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests | 2022 |
Effects of Boric Acid Gel on Vaginal
Topics: Animals; Boric Acids; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Cytokines; Female; Humans; Interleukin-10; Interleukin-17; Interleukin-4; Interleukin-6; Mice; Th17 Cells; Transforming Growth Factor beta | 2022 |
Fluconazole-Resistant Candida albicans Vaginal Infections at a Referral Center and Treated With Boric Acid.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Referral and Consultation; Retrospective Studies | 2023 |
Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents, Local; Boric Acids; Candidiasis, Vulvovaginal; Drug Administration Schedule; Female; Humans; Middle Aged; Patient Satisfaction; Recurrence; Retrospective Studies; Treatment Outcome; Vaginosis, Bacterial | 2019 |
Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center.
Topics: Adult; Aged; Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Middle Aged; Tertiary Healthcare; Treatment Outcome | 2016 |
Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
Topics: Antifungal Agents; Bacteria; Boric Acids; Candida albicans; Candidiasis, Vulvovaginal; Colony Count, Microbial; Ergosterol; Female; Humans; Microbial Sensitivity Tests; Microbial Viability | 2009 |
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Boric Acids; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cell Adhesion; Epithelial Cells; Female; Fluconazole; Fungal Proteins; Hemolysis; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Phospholipases; Pregnancy; Pregnancy Complications, Infectious; Recurrence; Saccharomyces cerevisiae; Vagina; Virulence Factors; Young Adult | 2012 |
Boric acid susceptibility testing of non-C. albicans Candida and Saccharomyces cerevisiae: comparison of three methods.
Topics: Agar; Anti-Infective Agents, Local; Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Culture Media; Female; Humans; Microbial Sensitivity Tests; Mycoses; Saccharomyces cerevisiae; Trichosporon; Vulvovaginitis | 2002 |
Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Boric Acids; Candida glabrata; Candidiasis, Vulvovaginal; Female; Flucytosine; Humans; Middle Aged; Ointments; Retreatment; Retrospective Studies; Vaginitis | 2003 |
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates.
Topics: Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Coumarins; Drug Interactions; Female; Humans; Microbial Sensitivity Tests; Plant Extracts; Plant Oils; Vagina | 2005 |
Nystatin versus boric acid powder in vulvovaginal candidiasis.
Topics: Boric Acids; Candidiasis, Vulvovaginal; Female; Humans; Nystatin; Powders | 1982 |
Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intravaginal; Adult; Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Fluconazole; Humans; Suppositories | 1997 |
Vaginitis.
Topics: Animals; Boric Acids; Candidiasis, Vulvovaginal; Female; Humans; Pregnancy; Vaginitis | 1998 |
Susceptibility of Candida species isolated from female prostitutes with vulvovaginitis to antifungal agents and boric acid.
Topics: Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Humans; Microbial Sensitivity Tests; Sex Work | 1999 |
Boric acid for yeast infections.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Humans; Itraconazole; Secondary Prevention; Suppositories; United States | 2001 |
Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid.
Topics: Administration, Intravaginal; Boric Acids; Candida; Candidiasis, Vulvovaginal; Female; Humans; Middle Aged | 2001 |
The treatment of inveterate vulvo-vaginal candidosis.
Topics: Adrenal Cortex Hormones; Boric Acids; Candidiasis, Vulvovaginal; Chronic Disease; Clotrimazole; Contraceptives, Oral; Diabetes Complications; Female; Humans; Menstrual Cycle; Miconazole; Nystatin; Patient Compliance; Rectum; Sexual Behavior; Suppositories; Thyroid Function Tests; Vagina | 1986 |